Australia Interventional Cardiology Market Outlook to 2033: Coronary Stents, PTCA Balloon Catheters, Structural Heart Occlusion Devices and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

GlobalData’s “Australia Interventional Cardiology Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Australia Interventional Cardiology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloon Catheters, Structural Heart Occlusion Devices and Transcatheter Accessories

The Australia Interventional Cardiology Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Interventional Cardiology Market.
• Global corporate-level profiles of key companies operating within the Australia Interventional Cardiology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Australia Interventional Cardiology is segmented as follows – _x000D_

• Coronary Stents_x000D_

• Intravascular Ultrasound Systems (IVUS)_x000D_

• PTCA Balloon Catheters_x000D_

• Structural Heart Occlusion Devices_x000D_

• Transcatheter Accessories

Reasons to Buy

Key Reasons to Purchase – The Australia Interventional Cardiology Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Abbott Laboratories_x000D_
ACIST Medical Systems Inc_x000D_
Asahi Intecc Co Ltd_x000D_
AtriCure Inc_x000D_
B. Braun Melsungen AG_x000D_
Biotronik SE & Co KG_x000D_
Boston Scientific Corp_x000D_
Cordis Corp_x000D_
InfraReDx Inc_x000D_
Koninklijke Philips NV_x000D_
Lepu Medical Technology (Beijing) Co Ltd

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 6

2.1 What Is This Report About? 6

2.2 Interventional Cardiology Market Segmentation 6

2.3 Definitions of Markets Covered in the Report 7

3 Interventional Cardiology Market, Australia 11

3.1 Interventional Cardiology Market, Australia, Revenue ($m), 2018-2033 11

3.1.1 Coronary Stents Market, Australia, Revenue ($m), by Segment, 2018-2033 13

3.1.2 Intravascular Ultrasound Systems (IVUS) Market, Australia, Revenue ($m), by Segment, 2018-2033 15

3.1.3 PTCA Balloon Catheters Market, Australia, Revenue ($m), by Segment, 2018-2033 17

3.1.4 Structural Heart Occlusion Devices Market, Australia, Revenue ($m), by Segment, 2018-2033 19

3.1.5 Transcatheter Accessories Market, Australia, Revenue ($m), by Segment, 2018-2033 21

3.2 Interventional Cardiology Market, Australia, Volume (Units), 2018-2033 23

3.2.1 Coronary Stents Market, Australia, Volume (Units), by Segment, 2018-2033 26

3.2.2 Intravascular Ultrasound Systems (IVUS) Market, Australia, Volume (Units), by Segment, 2018-2033 28

3.2.3 PTCA Balloon Catheters Market, Australia, Volume (Units), by Segment, 2018-2033 30

3.2.4 Structural Heart Occlusion Devices Market, Australia, Volume (Units), by Segment, 2018-2033 32

3.2.5 Transcatheter Accessories Market, Australia, Volume (Units), by Segment, 2018-2033 34

3.3 Interventional Cardiology Market, Australia, Average Price ($) , 2018-2033 36

3.4 Interventional Cardiology Market, Australia, Company Share by Revenue ($m), 2024 40

4 Overview of Key Companies in Australia, Interventional Cardiology Market 42

4.1 Boston Scientific Corp 42

4.1.1 Company Overview 42

4.2 Terumo Corp 42

4.2.1 Company Overview 42

4.3 Abbott Laboratories 42

4.3.1 Company Overview 42

4.4 Medtronic Plc 42

4.4.1 Company Overview 42

4.5 Asahi Intecc Co Ltd 43

4.5.1 Company Overview 43

4.6 Koninklijke Philips NV 43

4.6.1 Company Overview 43

4.7 W. L. Gore & Associates Inc 43

4.7.1 Company Overview 43

4.8 Biotronik SE & Co KG 43

4.8.1 Company Overview 43

4.9 Shockwave Medical Inc 44

4.9.1 Company Overview 44

4.10 B. Braun Melsungen AG 44

4.10.1 Company Overview 44

5 Interventional Cardiology Market Pipeline Products 45

6 Recent Developments 47

6.1 Financial Announcements 47

6.1.1 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024 47

6.2 Government and Public Interest 47

6.2.1 Apr 15, 2025: Leading Australian Private Hospital Chooses Sectra’s Enterprise Imaging Solution for Efficient Workflows and Better Patient Outcomes 47

6.3 Strategy And Business Planning 48

6.3.1 Mar 05, 2025: Clarity Signs Cu-64 Supply Agreement With the University of Queensland 48

7 Appendix 50

7.1 Research Methodology 51

7.1.1 Coverage 51

7.1.2 Secondary Research 51

7.1.3 Primary Research 51

7.1.4 Market Modeling and Forecasting 52

7.1.5 Company Share Analysis 53

7.1.6 Benchmarking 54

7.2 GlobalData Consulting 55

7.3 Contact Us 55

7.4 Disclaimer 55

Table

Table 1: Interventional Cardiology Market, Australia, Revenue ($m), USD Constant, 2018-2033 12

Table 2: Coronary Stents Market, Australia, Revenue ($m), USD Constant, 2018-2033 14

Table 3: Intravascular Ultrasound Systems (IVUS) Market, Australia, Revenue ($m), USD Constant, 2018-2033 16

Table 4: PTCA Balloon Catheters Market, Australia, Revenue ($m), USD Constant, 2018-2033 18

Table 5: Structural Heart Occlusion Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 20

Table 6: Transcatheter Accessories Market, Australia, Revenue ($m), USD Constant, 2018-2033 22

Table 7: Interventional Cardiology Market, Australia, Volume (Units), 2018-2033 24

Table 8: Coronary Stents Market, Australia, Volume (Units), 2018-2033 27

Table 9: Intravascular Ultrasound Systems (IVUS) Market, Australia, Volume (Units), 2018-2033 29

Table 10: PTCA Balloon Catheters Market, Australia, Volume (Units), 2018-2033 31

Table 11: Structural Heart Occlusion Devices Market, Australia, Volume (Units), 2018-2033 33

Table 12: Transcatheter Accessories Market, Australia, Volume (Units), 2018-2033 35

Table 13: Interventional Cardiology Market, Australia, Average Price ($), 2018-2033 36

Table 14: Interventional Cardiology Market, Australia, Company Share by Revenue ($m), 2024 41

Table 15: Interventional Cardiology Market Pipeline Products 45

Table 16: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country 52

Figures

Figure 1: Interventional Cardiology Market, Australia, Revenue ($m), USD Constant, 2018-2033 11

Figure 2: Coronary Stents Market, Australia, Revenue ($m), USD Constant, 2018-2033 13

Figure 3: Intravascular Ultrasound Systems (IVUS) Market, Australia, Revenue ($m), USD Constant, 2018-2033 15

Figure 4: PTCA Balloon Catheters Market, Australia, Revenue ($m), USD Constant, 2018-2033 17

Figure 5: Structural Heart Occlusion Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 19

Figure 6: Transcatheter Accessories Market, Australia, Revenue ($m), USD Constant, 2018-2033 21

Figure 7: Interventional Cardiology Market, Australia, Volume (Units), 2018-2033 23

Figure 8: Coronary Stents Market, Australia, Volume (Units), 2018-2033 26

Figure 9: Intravascular Ultrasound Systems (IVUS) Market, Australia, Volume (Units), 2018-2033 28

Figure 10: PTCA Balloon Catheters Market, Australia, Volume (Units), 2018-2033 30

Figure 11: Structural Heart Occlusion Devices Market, Australia, Volume (Units), 2018-2033 32

Figure 12: Transcatheter Accessories Market, Australia, Volume (Units), 2018-2033 34

Figure 13: Interventional Cardiology Market, Australia, Company Share (%), 2024 40

Australia Interventional Cardiology Market Outlook to 2033: Coronary Stents, PTCA Balloon Catheters, Structural Heart Occlusion Devices and Others standard reports
Currency USD
$4,995

Can be used by individual purchaser only

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Australia Interventional Cardiology Market Outlook to 2033: Coronary Stents, PTCA Balloon Catheters, Structural Heart Occlusion Devices and Others was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Australia Interventional Cardiology Market Outlook to 2033: Coronary Stents, PTCA Balloon Catheters, Structural Heart Occlusion Devices and Others in real time.

  • Access a live Australia Interventional Cardiology Market Outlook to 2033: Coronary Stents, PTCA Balloon Catheters, Structural Heart Occlusion Devices and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.